
Ketamine for PTSD in 2026: What the Clinical Evidence Shows and Who It Helps Most
PTSD is one of the most under-treated mental health conditions in the country and one of the least responsive to conventional medication. SSRIs produce a

PTSD is one of the most under-treated mental health conditions in the country and one of the least responsive to conventional medication. SSRIs produce a

When patients evaluate medications, they typically focus on the compound — semaglutide vs. tirzepatide, troches vs. nasal spray. What they often overlook is that the

The clinical evidence for psychedelic-assisted therapy has reached a point where it can no longer be dismissed as fringe science. Multiple Phase 3 clinical trials

The appeal of stacking longevity therapies is intuitive — if NAD supports mitochondrial function and glutathione addresses oxidative stress, why not use both? The logic

Most men who start testosterone replacement therapy receive a clear explanation of what testosterone does for them. What they rarely receive is an equally clear

GLP-1 medications became famous for weight loss. But emerging research suggests their effects on the brain go well beyond appetite suppression. Patients on semaglutide and

Mental health care access in the United States is not distributed according to need. It is distributed according to geography, income, and insurance status —

Something significant is happening in the way Americans approach their health. For decades, the dominant model was the supplement aisle — vitamins, minerals, and herbal

Asking which weight loss medication is best is a little like asking which tool in a workshop is most useful. The answer depends entirely on
Daytryp Chat